Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

J&J to recall some baby powder as FDA finds traces of asbestos

Johnson & Johnson is recalling around 33,000 bottles of baby powder in the United States after the U.S. health regulators found trace amounts of asbestos in samples taken from a bottle purchased online.

Read More »

Depression drug Spravato wins European panel vote

Johnson & Johnson’s Spravato, a nasal spray for depression and potential blockbuster medicine, won recommendation for approval from a European Medicines Agency panel.

Read More »

WHO hails ‘triumph’ as Merck’s Ebola vaccine gets European green light

The world’s first Ebola vaccine was recommended for approval by European drug regulators in a move hailed by the World Health Organization (WHO) as a “triumph for public health.”

Read More »

Juul halts all U.S. sales of many flavored nicotine liquids

E-cigarette maker Juul Labs Inc. will completely halt U.S. sales of all flavors except tobacco, mint and menthol as the company faces heightened scrutiny from regulators, lawmakers and state attorneys general over the appeal of the company’s nicotine products to teenagers.

Read More »

Johnson & Johnson agrees to pay about $117 million to settle vaginal mesh litigation

U.S. state attorneys general said Johnson & Johnson and a company unit agreed to pay nearly $117 million to settle litigation over deceptive marketing of transvaginal surgical mesh devices.

Read More »

Breast cancer drug gets FDA priority review

The U.S. drug regulator will give a speedy review to AstraZeneca Plc’s experimental breast cancer treatment trastuzumab deruxtecan.

Read More »

Pancreatic cancer drug combo fails late-stage study

Eli Lilly and Co.’s experimental pancreatic cancer treatment in combination with chemotherapy drugs failed to meet the main goal of overall survival in a late-stage study.

Read More »

Alexion fortifies rare blood disorder drugs business

Alexion Pharmaceuticals Inc. agreed to buy smaller biotech company Achillion Pharmaceuticals Inc. in a deal initially valued at $930 million.

Read More »

Roche lifts 2019 sales view again as Chinese demand soars

Roche lifted the Swiss drugmaker’s 2019 sales target for the third time during the year, helped by newer medicines and as China bought more cancer drugs to treat a disease blamed for a quarter of the nation’s annual deaths.

Read More »

Missouri appeals court overturns J&J talc verdict

A Missouri appeals court overturned a $110 million verdict against Johnson & Johnson in a lawsuit by a Virginia woman who says she developed ovarian cancer after decades of using of the company’s talc-based products for feminine hygiene.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom